(Reuters) - Amgen Inc reported higher first-quarter earnings on Tuesday, helped by price increases for its best-selling drugs, as well as lower spending on research and development.
Amgen shares, which rose 1.5 percent in regular trading, were up another 2.3 percent at $172.25 after hours.
22:53 LG Display reports record fourth quarter profit of $778 million16
01:45 Japanese shares fall 1% as yen strengthens, Samsung presser announcements ahead18
19:39 $1M '100 percent Swiss Made' watch made of real Swiss cheese16
23:37 Here’s Why Netflix’s Share Price Just Hit a New All-Time High11